Discovery of Benzenesulfonamides with Potent Human Carbonic Anhydrase Inhibitory and Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Assessment
Discovery of Benzenesulfonamides with Potent Human Carbonic Anhydrase Inhibitory and Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Assessment(818 views) Mishra CB, Kumari S, Angeli A, Monti SM, Buonanno M, Tiwari M, Supuran CT
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2017 Mar 23; 60(6): 2456-2469.
Bio-Organic Chemistry Laboratory, Dr. B. R. Ambedkar Centre for Biomedical Research, University of Delhi , Delhi, India., Dipartimento Neurofarba, Universita degli Studi di Firenze, Sezione di Scienze Farmaceutiche e Nutraceutiche , Florence, Italy., Istituto di Biostrutture e Bioimmagini (IBB) CNR ,via Mezzocannone, Naples, Italy.,
References: http://www.who.int/mediacentre/factsheets/fs999/en/, WHO Data (accessed Feb 3, 2016)
Fisher, R.S., Van Emde, B.W., Blume, W., Elger, C., Genton, P., Lee, P., Engel, J., Jr., Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) (2005) Epilepsia, 46, pp. 470-47
Kumari, S., Mishra, C.B., Tiwari, M., Polypharmacological drugs in the treatment of epilepsy: the comprehensive review of marketed and new emerging molecules (2016) Curr. Pharm. Des., 22, pp. 3212-3225
Meldrum, B.S., Rogawski, M.A., Molecular targets for antiepileptic drug development (2007) Neurotherapeutics, 4, pp. 18-61
Bonnet, U., Wiemann, M., Bingmann, D., CO2/HCO3(−)-withdrawal from the bath medium of hippocampal slices: biphasic effect on intracellular pH and bioelectric activity of CA3-neurons (1998) Brain Res., 796, pp. 161-170
Velisek, L., Dreier, J.P., Stanton, P.K., Heinemann, U., Moshe, S.L., Lowering of extracellular pH suppresses low-Mg(2+)-induces seizures in combined entorhinal cortex-hippocampal slices (1994) Exp. Brain Res., 101, pp. 44-52
Xiong, Z.Q., Saggau, P., Stringer, J.L., Activity-dependent intracellular acidification correlates with the duration of seizure activity (2000) J. Neurosci., 20, pp. 1290-1296
Aribi, A.M., Stringer, J.L., Effects of antiepileptic drugs on extracellular pH regulation in the hippocampal CA1 region in vivo (2002) Epilepsy Res., 49, pp. 143-151
Chen, J.C., Chesler, M., pH transients evoked by excitatory synaptic transmission are increased by inhibition of extracellular carbonic anhydrase (1992) Proc. Natl. Acad. Sci. U. S. A., 89, pp. 7786-7790
Casini, A., Antel, J., Abbate, F., Scozzafava, A., David, S., Waldeck, H., Schafer, S., Supuran, C.T., Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV (2003) Bioorg. Med. Chem. Lett., 13, pp. 841-845
Di Fiore, A., De Simone, G., Alterio, V., Riccio, V., Winum, J.Y., Carta, F., Supuran, C.T., The anticonvulsant sulfamide JNJ-26990990 and its S,S-dioxide analog strongly inhibit carbonic anhydrases: solution and X-ray crystallographic studies (2016) Org. Biomol. Chem., 14, pp. 4853-4858
Supuran, C.T., Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors (2016) Expert Opin. Drug Metab. Toxicol., 12, pp. 423-431
Alterio, V., Di Fiore, A., D’Ambrosio, K., Supuran, C.T., De Simone, G., Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms? (2012) Chem. Rev., 112, pp. 4421-4468
Supuran, C.T., How many carbonic anhydrase inhibition mechanisms exist? (2016) J. Enzyme Inhib. Med. Chem., 31, pp. 345-360
Rummer, J.L., McKenzie, D.J., Innocenti, A., Supuran, C.T., Brauner, C.J., Root effect hemoglobin may have evolved to enhance general tissue oxygen delivery (2013) Science, 340, pp. 1327-1329
Neri, D., Supuran, C.T., Interfering with pH regulation in tumors as a therapeutic strategy (2011) Nat. Rev. Drug Discovery, 10, pp. 767-777
Smith, K.S., Jakubzick, C., Whittam, T.S., Ferry, J.G., Carbonic anhydrase is an ancient enzyme widespread in prokaryotes (1999) Proc. Natl. Acad. Sci. U. S. A., 96, pp. 15184-15189
Supuran, C.T., Structure-based drug discovery of carbonic anhydrase inhibitors (2012) J. Enzyme Inhib. Med. Chem., 27, pp. 759-772
Aggarwal, M., Boone, C.D., Kondeti, B., McKenna, R., Structural annotation of human carbonic anhydrases (2013) J. Enzyme Inhib. Med. Chem., 28, pp. 267-277
Xu, Y., Feng, L., Jeffrey, P.D., Shi, Y., Morel, F.M., Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms (2008) Nature, 452, pp. 56-61
Mishra, C.B., Kumari, S., Angeli, A., Monti, S.M., Buonanno, M., Prakash, A., Tiwari, M., Supuran, C.T., Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/ 1,3,4-thiadiazol-2-yl)-4-(3 substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors (2016) J. Enzyme Inhib. Med. Chem., 31, pp. 174-179
Borras, J., Scozzafava, A., Menabuoni, L., Mincione, F., Briganti, F., Mincione, G., Supuran, C.T., Carbonic anhydrase inhibitors. Part 73. Synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/ heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring ? (1999) Bioorg. Med. Chem., 7, pp. 2397-2406
Cottier, F., Leewattanapasuk, W., Kemp, L.R., Murphy, M., Supuran, C.T., Kurzai, O., Mühlschlegel, F.A., Carbonic anhydrase regulation and CO2 sensing in the fungal pathogen Candida glabrata involves a novel Rca1p ortholog (2013) Bioorg. Med. Chem., 21, pp. 1549-1554
Schlicker, C., Hall, R.A., Vullo, D., Middelhaufe, S., Gertz, M., Supuran, C.T., Mühlschlegel, F.A., Steegborn, C., Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans (2009) J. Mol. Biol., 385, pp. 1207-1220
Filippi, D., Sciaky, M., Limozin, N., Laurent, G., Anhydrase carbonique du système nerveux central du rat. Isolement et propriétés (1978) Biochimie, 60, pp. 99-102
Agnati, L.F., Tinner, B., Staines, W.A., Vaananen, K., Fuxe, K., On the cellular localization and distribution of carbonic anhydrase II immunoreactivity in the rat brain (1995) Brain Res., 676, pp. 10-24
Parkkila, S., An Overview of the Distribution and Function of Carbonic Anhydrase in Mammals (2000) The Carbonic Anhydrases: New Horizons, pp. 79-93. , Chegwidden, R. Ed. Birkäuser Verlag: Basel, Switzerland
Halmi, P., Parkkila, S., Honkaniemi, J., Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus (2006) Neurochem. Int., 48, pp. 24-30
Masuzawa, T., Sato, F., The enzyme histochemistry of the choroid plexus (1983) Brain, 106, pp. 55-99
Velisek, L., Moshe, S.L., Cammer, W., Developmental changes in seizure susceptibility in carbonic anhydrase II-deficient mice and normal littermates (1993) Dev. Brain Res., 72, pp. 321-324
De Simone, G., Scozzafava, A., Supuran, C.T., Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates? (2009) Chem. Biol. Drug Des., 74, pp. 317-321
Ruusuvuori, E., Kaila, K., Carbonic Anhydrases and Brain pH in the Control of Neuronal Excitability (2014) Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications, pp. 271-290. , Frost, S. McKenna, R. Eds. Springer: New York
Ruusuvuori, E., Huebner, A.K., Kirilkin, I., Yukin, A.Y., Blaesse, P., Helmy, M., Kang, H.J., Kaila, K., Neuronal carbonic anhydrase VII provides GABAergic excitatory drive to exacerbate febrile seizures (2013) EMBO J., 32, p. 2275
Ruusuvuori, E., Li, H., Huttu, K., Palva, J.M., Smirnov, S., Rivera, C., Kaila, K., Voipio, J., Carbonic anhydrase isoform VII acts as a molecular switch in the development of synchronous gamma-frequency firing of hippocampal CA1 pyramidal cells (2004) J. Neurosci., 24, pp. 2699-2707
Rivera, C., Voipio, J., Kaila, K., Two developmental switches in GABAergic signalling: the K+-Cl- cotransporter KCC2 and carbonic anhydrase CAVII (2005) J. Physiol., 562, pp. 27-36
Nishimori, I., Acatalytic CAs: Carbonic Anhydrase Related Proteins (2004) Carbonic Anhydrase: Its Inhibitors and Activators, pp. 25-43. , Supuran, C. T. Scozzafava, A. Conway, J. Eds. CRC Press: Boca Raton, FL
Chesler, M., Regulation and modulation of pH in the brain (2003) Physiol. Rev., 83, pp. 1183-1221
Casey, J.R., Grinstein, S., Orlowski, J., Sensors and regulators of intracellular pH (2010) Nat. Rev. Mol. Cell Biol., 11, pp. 50-61
Ruusuvuori, E., Kirilkin, I., Pandya, N., Kaila, K., Spontaneous network events driven by depolarizing GABA action in neonatal hippocampal slices are not attributable to deficient mitochondrial energy metabolism (2010) J. Neurosci., 30, pp. 15638-15642
Pasternack, M., Voipio, J., Kaila, K., Intracellular carbonic anhydrase activity and its role in GABA-induced acidosis in isolated rat hippocampal pyramidal neurones (1993) Acta Physiol. Scand., 148, pp. 229-231
Williams, R.H., Jensen, L.T., Verkhratsky, A., Fugger, L., Burdakov, D., Control of hypothalamic orexin neurons by acid and CO2 (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 10685-10690
Vullo, D., Innocenti, A., Nishimori, I., Pastorek, J., Scozzafava, A., Pastorekova, S., Supuran, C.T., Carbonic anhydrase inhibitors: Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs? (2005) Bioorg. Med. Chem. Lett., 15, pp. 963-969
Vullo, D., Voipio, J., Innocenti, A., Rivera, C., Ranki, H., Scozzafava, A., Kaila, K., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides (2005) Bioorg. Med. Chem. Lett., 15, pp. 971-976
Reiss, W.G., Oles, K.S., Acetazolamide in the treatment of seizures (1996) Ann. Pharmacother., 30, pp. 514-519
Katayama, F., Miura, H., Takanashi, S., Long-term effectiveness and side effects of acetazolamide as an adjunct to other anticonvulsants in the treatment of refractory epilepsies (2002) Brain Dev., 24, pp. 150-154
Parkkila, S., Parkkila, A.K., Kivela, J., Role of Carbonic Anhydrase and Its Inhibitors in Gastroenterology, Neurology and Nephrology (2004) Carbonic Anhydrase: Its Inhibitors and Activators, pp. 283-301. , Supuran, C. T. Scozzafava, A. Conway, J. Eds. CRC Press: Boca Raton, FL
Leppik, I.E., Zonisamide: chemistry, mechanism of action, and pharmacokinetics (2004) Seizure, 13, pp. S5-S9
Bialer, M., Johannessen, S.I., Kupferberg, H.J., Levy, R.H., Loiseau, P., Perucca, E., Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V) (2001) Epilepsy Res., 43, pp. 11-58
Herrero, A.I., Del Olmo, N., Gonzalez-Escalada, J.R., Solis, J.M., Two new actions of topiramate: inhibition of depolarizing GABA (A)-mediated responses and activation of a potassium conductance (2002) Neuropharmacology, 42, pp. 210-220
Ilies, M.A., Masereel, B., Rolin, S., Scozzafava, A., Campeanu, G., Cimpeanu, V., Supuran, C.T., Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity (2004) Bioorg. Med. Chem., 12, pp. 2717-2726
Leniger, T., Thone, J., Wiemann, M., Topiramate modulates pH of hippocampal CA3 neurons by combined effects on carbonic anhydrase and Cl-/HCO3 - exchange (2004) Br. J. Pharmacol., 142, pp. 831-842
Supuran, C.T., Advances in structure-based drug discovery of carbonic anhydrase inhibitors (2017) Expert Opin. Drug Discovery, 12, pp. 61-88
Arechederra, R.L., Waheed, A., Sly, W.S., Supuran, C.T., Minteer, S.D., Effect of sulfonamides as selective carbonic anhydrase VA and VB inhibitors on mitochondrial metabolic energy conversion (2013) Bioorg. Med. Chem., 21, pp. 1544-1548
Masini, E., Carta, F., Scozzafava, A., Supuran, C.T., Antiglaucoma carbonic anhydrase inhibitors: A patent review (2013) Expert Opin. Ther. Pat., 23, pp. 705-716
Aggarwal, M., McKenna, R., Update on carbonic anhydrase inhibitors: a patent review (2008-2011) (2012) Expert Opin. Ther. Pat., 22, pp. 903-915
Aggarwal, M., Kondeti, B., McKenna, R., Anticonvulsant/ antiepileptic carbonic anhydrase inhibitors: a patent review (2013) Expert Opin. Ther. Pat., 23, pp. 717-724
Supuran, C.T., Dognè, J.M., Thiry, A., Masereel, B., Anticonvulsant sulfonamides/sulfamates/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action (2008) Curr. Pharm. Des., 14, pp. 661-671
Fabrizi, F., Mincione, F., Somma, T., Scozzafava, G., Galassi, F., Masini, E., Impagnatiello, F., Supuran, C.T., A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology (2012) J. Enzyme Inhib. Med. Chem., 27, pp. 138-147
Thiry, A., Dognè, J.M., Masereel, B., Supuran, C.T., Carbonic anhydrase inhibitors as anticonvulsant agents (2007) Curr. Top. Med. Chem., 7, pp. 855-864
Ilies, M.A., Vullo, D., Pastorek, J., Scozzafava, A., Ilies, M., Caproiu, M.T., Pastorekova, S., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX with halogenosulfanilamide and halogenophenylaminobenzolamide derivatives (2003) J. Med. Chem., 46, pp. 2187-2196
Supuran, C.T., Ilies, M.A., Scozzafava, A., Carbonic anhydrase inhibitors. Part 29. Interaction of isozymes I, II and IV with benzolamide-like derivatives (1998) Eur. J. Med. Chem., 33, pp. 739-752
Vullo, D., Supuran, C.T., Scozzafava, A., De Simone, G., Monti, S.M., Alterio, V., Carta, F., Kinetic and X-ray crystallographic investigations of substituted 2-thio-6-oxo-1,6 dihydropyrimidine-benzenesulfonamides acting as carbonic anhydrase inhibitors (2016) Bioorg. Med. Chem., 24, pp. 3643-3648
Di Fiore, A., Capasso, C., De Luca, V., Monti, S.M., Carginale, V., Supuran, C.T., Scozzafava, A., De Simone, G., X-ray structure of the first ̀extremo-α-carbonic anhydrase’, a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 (2013) Acta Crystallogr., Sect. D: Biol. Crystallogr., 69, pp. 1150-1159
Ilies, M., Supuran, C.T., Scozzafava, A., Casini, A., Mincione, F., Menabuoni, L., Caproiu, M.T., Banciu, M.D., Carbonic anhydrase inhibitors: Sulfonamides incorporating furan, thiophene- and pyrrole-carboxamido groups possess strong topical intraocular pressure lowering properties as aqueous suspensions (2000) Bioorg. Med. Chem., 8, pp. 2145-2155
Scozzafava, A., Mastrolorenzo, A., Supuran, C.T., Arylsulfonyl-N, N-diethyl-dithiocarbamates: A novel class of antitumor agents (2000) Bioorg. Med. Chem. Lett., 10, pp. 1887-1891
Güzel, O., Maresca, A., Scozzafava, A., Salman, A., Balaban, A.T., Supuran, C.T., Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII (2009) Bioorg. Med. Chem. Lett., 19, pp. 2931-2934
Brzozowski, Z., Slawinski, J., Innocenti, A., Supuran, C.T., Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3 pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII (2010) Eur. J. Med. Chem., 45, pp. 3656-3661
Akdemir, A., Güzel-Akdemir, O., Scozzafava, A., Capasso, C., Supuran, C.T., Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides (2013) Bioorg. Med. Chem., 21, pp. 5228-5232
Thiry, A., Rolin, S., Vullo, D., Frankart, A., Scozzafava, A., Dogne, J., Wouters, J., Masereel, B., Indanesulfonamides as carbonic anhydrase inhibitors and anticonvulsant agents: Structureeactivity relationship and pharmacological evaluation (2008) Eur. J. Med. Chem., 43, pp. 2853-2860
Leitans, J., Sprudza, A., Tanc, M., Vozny, I., Zalubovskis, R., Tars, K., Supuran, C.T., 5-Substituted-(1, 2, 3-triazol-4-yl) thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: Solution and X-ray crystallographic studies (2013) Bioorg. Med. Chem., 21, pp. 5130-5138
Nishimori, I., Vullo, D., Innocenti, A., Scozzafava, A., Mastrolorenzo, A., Supuran, C.T., Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors (2005) J. Med. Chem., 48, pp. 7860-7866
Mete, E., Comez, B., Inci Gul, H., Gulcin, I., Supuran, C.T., Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides (2016) J. Enzyme Inhib. Med. Chem., 31, pp. 1-5
Bozdag, M., Alafeefy, A.M., Carta, F., Ceruso, M., Al-Tamimi, A.S., Al-Kahtani, A.A., Alasmary, F.A.S., Supuran, C.T., Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]- benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties (2016) Bioorg. Med. Chem., 24, pp. 4100-4107
Abdel Gawad, N.M., Amin, N.H., Elsaadi, M.T., Mohamed, F.M., Angeli, A., De Luca, V., Capasso, C., Supuran, C.T., Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines (2016) Bioorg. Med. Chem., 24, pp. 3043-3051
Supuran, C.T., Kalinin, S., Tanç, M., Sarnpitak, P., Mujumdar, P., Poulsen, S.A., Krasavin, M., Isoform-selective inhibitory profile of 2-imidazoline-substituted benzene sulfonamides against a panel of human carbonic anhydrases (2016) J. Enzyme Inhib. Med. Chem., 31, pp. 197-202
Gul, H.I., Tugrak, M., Sakagami, H., Taslimi, P., Gulcin, I., Supuran, C.T., Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a,4-dihydro-3H-indeno[1,2-c]pyrazol-2-yl) benzenesulfonamides (2016) J. Enzyme Inhib. Med. Chem., 31, pp. 1619-1624
Eldehna, W.M., Fares, M., Ceruso, M., Ghabbour, H.A., Abou-Seri, S.M., Abdel-Aziz, H.A., Abou El Ella, D.A., Amido/ ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII (2016) Eur. J. Med. Chem., 110, pp. 259-266
Lomelino, C.L., Mahon, B.P., McKenna, R., Carta, F., Supuran, C.T., Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111 (2016) Bioorg. Med. Chem., 24, pp. 976-981
Cornelio, B., Laronze-Cochard, M., Ceruso, M., Ferraroni, M., Rance, G.A., Carta, F., Khlobystov, A.N., Sapi, J., 4-Arylbenzenesulfonamides as human carbonic anhydrase Inhibitors (hCAIs): Synthesis by Pd nanocatalyst-mediated Suzuki- Miyaura reaction, enzyme inhibition, and X-ray crystallographic studies (2016) J. Med. Chem., 59, pp. 721-732
La Regina, G., Coluccia, A., Famiglini, V., Pelliccia, S., Monti, L., Vullo, D., Nuti, E., Silvestri, R., Discovery of 1, 1′-biphenyl-4-sulfonamides as a new class of potent and selective carbonic anhydrase XIV inhibitors (2015) J. Med. Chem., 58, pp. 8564-8572
Rankin, G.M., Vullo, D., Supuran, C.T., Poulsen, S.A., Phosphate chemical probes designed for location specific inhibition of intracellular carbonic anhydrases (2015) J. Med. Chem., 58, pp. 7580-7590
Wilkinson, B.L., Innocenti, A., Vullo, D., Supuran, C.T., Poulsen, S.A., Inhibition of Carbonic anhydrases with glycosyltriazole benzene sulfonamides (2008) J. Med. Chem., 51, pp. 1945-1953
Casini, A., Scozzafava, A., Mincione, F., Menabuoni, L., Ilies, M.A., Supuran, C.T., Carbonic anhydrase inhibitors: water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects (2000) J. Med. Chem., 43, pp. 4884-4892
Bozdag, M., Pinard, M., Carta, F., Masini, E., Scozzafava, A., McKenna, R., Supuran, C.T., A class of 4-sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects (2014) J. Med. Chem., 57, pp. 9673-9686
Innocenti, A., Casini, A., Alcaro, M.C., Papini, A.M., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: the first on-resin screening of a 4-sulfamoylphenylthiourea library (2004) J. Med. Chem., 47, pp. 5224-5229
Pacchiano, F., Carta, F., McDonald, P.C., Lou, Y., Vullo, D., Scozzafava, A., Dedhar, S., Supuran, C.T., Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis (2011) J. Med. Chem., 54, pp. 1896-1902
Hen, N., Bialer, M., Yagen, B., Maresca, A., Aggarwal, M., Robbins, A.H., McKenna, R., Supuran, C.T., Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV (2011) J. Med. Chem., 54, pp. 3977-3981
Lou, Y., McDonald, P.C., Oloumi, A., Chia, S., Ostlund, C., Ahmadi, A., Kyle, A., Dedhar, S., Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors (2011) Cancer Res., 71, pp. 3364-3376
Pacchiano, F., Aggarwal, M., Avvaru, B.S., Robbins, A.H., Scozzafava, A., McKenna, R., Supuran, C.T., Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency (2010) Chem. Commun., 46, pp. 8371-8373
Congiu, C., Onnis, V., Deplano, A., Balboni, G., Dedeoglu, N., Supuran, C.T., Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity (2015) Bioorg. Med. Chem. Lett., 25, pp. 3850-3853
Mishra, C.B., Manral, A., Kumari, S., Saini, V., Tiwari, M., Novel indadinone derivatives as multitarget-directed agent with cholinesterase inhibition, anti-β-amyloid aggregation, antioxidant and neuroprotection properties against Alzheimer’s disease (2016) Bioorg. Med. Chem., 24, pp. 3829-3841
Shaquiquzzaman, M., Verma, G., Marella, A., Akhter, M., Akhtar, W., Khan, M.F., Tasneem, S., Alam, M.M., Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents (2015) Eur. J. Med. Chem., 102, pp. 487-529
Turkmen, H., Durgun, M., Yilmaztekin, S., Emul, M., Innocenti, A., Vullo, D., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX (2005) Bioorg. Med. Chem. Lett., 15, pp. 367-372
Abdülkadir Coban, T., Beydemir, S., Gülcin, I., Ekinci, D., Innocenti, A., Vullo, D., Supuran, C.T., Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I-XIV (2009) Bioorg. Med. Chem., 17, pp. 5791-5795
Sławiński, J., Szafrański, K., Vullo, D., Supuran, C.T., Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII (2013) Eur. J. Med. Chem., 69, pp. 701-710
Castel-Branco, M.M., Alves, G.L., Figueiredo, I.V., Falco, A.C., Caramona, M.M., The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs (2009) Methods Find. Exp. Clin. Pharmacol., 31, pp. 101-106
Huang, Q.R., Bell Horner, L.C., Mohammad, I.D., Covey, F.D., Drewe, J.A., Dillon, G.H., Pentylenetetrazole-induced inhibition of recombinant-aminobutyric acid type A (GABAA) receptors: mechanism and site of action (2001) J. Pharmacol. Exp. Ther., 298, pp. 986-995
Loscher, W., Honack, D., Fassbender, P.C., Nolting, B., The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models (1991) Epilepsy Res., 8, pp. 171-189
Litchfeld, J.T., Jr., Wilcoxon, F., A simplified method of evaluating dose-effect experiments (1949) J. Pharmacol. Exp. Ther., 96, pp. 99-113
Discovery of Benzenesulfonamides with Potent Human Carbonic Anhydrase Inhibitory and Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Assessment
Discovery of Benzenesulfonamides with Potent Human Carbonic Anhydrase Inhibitory and Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Assessment
Discovery of Benzenesulfonamides with Potent Human Carbonic Anhydrase Inhibitory and Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Assessment
Ciccarelli M, Sorriento D, Coscioni E, Iaccarino G, Santulli G * Adrenergic Receptors(261 views) Endocrinol Of The Heart In Health And Dis (ISSN: 9780-1280311249780128031117), 2016; N/D: 285-315. Impact Factor:0 ViewExport to BibTeXExport to EndNote
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(295 views) N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 ViewExport to BibTeXExport to EndNote